Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1993-12-10
1997-07-22
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
424 852, 424450, 424812, 4242831, 424423, 4241841, 4241551, 4242081, 4242341, 4242011, 4242001, 4242751, 4242041, A61K 4505, A61K 9127, A61K 3900, A61K 39395, A61K 200, A61K 3902, A61K 3935, A61K 3912
Patent
active
056501528
ABSTRACT:
The present invention provides a liposome comprising an effective immunoadjuvant amount of a lymphokine such as IL-2. Also provided is an effective antineoplastic amount of IL-2 liposomes in combination with adoptively transferred cells stimulated with anti-CD3 monoclonal antibody plus IL-2.
REFERENCES:
patent: 4199565 (1980-04-01), Fullerton
patent: 4229441 (1980-10-01), Bugianesi et al.
patent: 4235877 (1980-11-01), Fullerton
patent: 4311712 (1982-01-01), Evans et al.
patent: 4370349 (1983-01-01), Evans et al.
patent: 4464355 (1984-08-01), Fabricius et al.
patent: 4473495 (1984-09-01), Patterson
patent: 4484923 (1984-11-01), Amkraut et al.
patent: 4518584 (1985-05-01), Mark et al.
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 4565696 (1986-01-01), Heath et al.
patent: 4599227 (1986-07-01), Dees et al.
patent: 4604377 (1986-08-01), Fernandes et al.
patent: 4636463 (1987-01-01), Altman et al.
patent: 4663161 (1987-05-01), Mannino et al.
patent: 4683199 (1987-07-01), Palladino
patent: 4684625 (1987-08-01), Eppstein et al.
patent: 4689222 (1987-08-01), McMichael
patent: 4690915 (1987-09-01), Rosenberg
patent: 4721612 (1988-01-01), Janoff et al.
patent: 4752425 (1988-06-01), Martin et al.
patent: 4774085 (1988-09-01), Fidler
patent: 4781871 (1988-11-01), West, III et al.
patent: 4808151 (1989-02-01), Dunn, Jr. et al.
patent: 4844904 (1989-07-01), Hamaguchi et al.
patent: 4863740 (1989-09-01), Kissel et al.
patent: 4950647 (1990-08-01), Robins et al.
patent: 4963354 (1990-10-01), Shepard et al.
patent: 4975282 (1990-12-01), Cullis et al.
patent: 4983397 (1991-01-01), Schroit et al.
patent: 5019394 (1991-05-01), Hamaguchi et al.
patent: 5026557 (1991-06-01), Estis et al.
patent: 5030453 (1991-07-01), Lenk et al.
patent: 5100664 (1992-03-01), Doyle et al.
patent: 5229109 (1993-07-01), Grimm et al.
patent: 5409698 (1995-04-01), Anderson
Flier et al. 1993. Vaccines against human immunodeficiency virus-progress and prospects. New England J. Medicine 329(19): 1400-05.
Koff et al. 1988. Development and Testing of AIDS Vaccines. Science 241: 426-432.
Schild et al. 1990. Human immunodeficiency virus and AIDS: challenge and progress. The Lancet 335:1081-84.
Newell et al, 1988. J. Cell Biochem. Supl 128: 12, F022.
Gillman et al 1980, Annals of Allergy. 45:351-354.
Fukushima et al, 1981. Jap. J. Med. 20(4): 270.
Richards et al 1988 Biochemical Soc. Trans. 16: 921-22.
Wachsmann et al 1986, Infec & Imm. 52(2): 408-413.
Wetzler et al 1988 J. Exp. Med. 168: 1883-97.
Desidero et al 1985. Infect & Imm. 1985:48(3):658-63.
Sanchez et al 1980. Infec & Imm. 30(3): 728-733.
Naylor et al 1982, Infec & Imm 36(3): 1209-16.
Boudreault et al 1985 Vaccine 3: 231-34.
Vasantha et al, 1987. Acta virol 31: 109-115.
Perrin et al, 1985 Vaccine 3: 325-332.
Wassef et al 1994 Immunomethods 4:217-222.
Gregoriadis 1994, Immunomethods 4: 210-216.
Gordon, Vaccine 1993 11: 591-93.
T.D. Geppert et al., J. Clin. Invest., 81, 1497 (1988).
E.A. Grimm et al., J. Exp. Med., 155, 1823 (1982).
M.T. Lotze et al., Cancer Res., 41, 4420 (1981).
M.T. Lotze et al., J. Surg. Res., 42, 580 (1987).
E. Lotzova et al., Nat. Immun. Cell Growth Regul., 6, 219 (1987).
G.B. Mills et al., J. Cell. Physiol., 141, 310 (1989).
R.P. Moser et al., Int'l Symp. on Pediatric Neuro-Oncology, Jun. 1-3, 1989, Seattle, WA, Meeting Abstract No. A14.
S. Rosenberg, J.N.C.I., 75, 595 (1985).
P.M. Sondel et al., J. Immunol., 137, 502 (1986).
J. Stankova et al., FASEB, 2, (1988) Abstract No. 2114, 72nd Annual Meeting of FASEB, May 1988 (Meeting Abstract).
J. Stankova et al., Cell. Immunol., 121, 13 (1988).
M.C. Turco et al., Blood, 74, 1651 (1989).
W.H. West et al., J. Immunol., 118, 355 (1977).
P.M. Anderson et al., Cancer Immunol. Immunother., 1988, 27, 82.
P.M. Anderson et al., J. Biol. Chem., 1979, 254, 6924.
P.M. Anderson et al., J. Immunol., 1989, 142, 1383.
P.M. Anderson et al., Proceed. Amer. Assoc. Cancer Res., 1989, 30, 364.
P.M. Anderson et al., Abstract of paper presented at FASEB, New Orleans, Mar. 1989.
P.M. Anderson et al., J. Cell. Biochemistry, 1988, 12, Part B, 255, Abstract W100.
N. Berinstein et al., J. Immunol., 1988, 140, 2839.
C.G. Brooks et al., J. Immunol., 1985, 135, 1145.
M.J. Brunda et al., Int. J. Cancer, 1986, 37, 787.
D.J.A. Crommelin et al., Pharm. Res., 1984, 1, 159.
H.-A. Fabricius et al., Immunobiol., 1979, 156, 364.
R.I. Fisher et al., Ann. Int. Med., 1988, 108, 518.
E.A. Forssen et al., Cancer Res., 1983, 43, 546.
J.H. Frenster et al., in Proc. 5th Leukocyte Culture Conference, J. E. Harris, ed. (1970), p. 359.
C.J. Froelich et al., J. Immunol. Meth., 1986, 86, 205.
J. Fujita, Eur. J. Cancer Clin. Oncol., 1986, 22, 445.
S. Gillis et al., J. Immunol., 1978, 120, 2027.
M.F. Good et al., J. Immunol., 1988, 141, 972.
R.E. Gordon et al., Drug Dev. Ind. Pharm., 1982, 8, 465.
G. Gregoriadis and A. C. Allison, eds., Liposomes in Biological Systems, John Wiley & Sons, New York (1980), at pp. 153-178.
E.A. Grimm et al., J. Exp. Med., 1983, 158, 1356.
E.A. Grimm et al., J. Exp. Med., 1983, 157, 884.
H.H. Hsieh et al., Transplantation Proceedings, 1985, XVII, 1397.
K.J. Hwang, in Liposomes from Biophysics to Therapeutics, M.J. Ospro, ed., Marcel Decker, New York (1987) at pp. 109-156.
K. Itoh et al., J. Immunol., 1985, 134, 3124.
K. Itoh et al., J. Immunol., 1986, 136, 3910.
E.M. Janis et al., Science, 1989, 244, 713.
M. Kende et al., Antimicrobial Agents and Chemotherapy, 1985, 27, 903.
H. Konno et al., Chemical Abstracts, 1989, 110, No. 19, 624, Abstract No. 171523s.
S.S. Kulkarni et al., Annals of the New York Academy of Sciences, 1987, 507, 344.
O. Leo et al., Proc. Natl. Acad. Sci. USA, 1987, 84, 1374.
G. Lopez-Berestein, Ann. Int. Med., 1986, 105, 130.
M. Malkovsky et al., Nature, 1987, 325, 262.
S.C. Meuer et al., Proc. Natl. Acad. Sci. USA, 1984, 81, 1509.
S. Miescher et al., J. Immunol., 1986, 136, 1899.
J.J. Mule et al., Science, 1984, 225, 1487.
L.M. Muul et al., J. Immunol., 1987, 138, 989.
L.M. Muul et al., J. Immunol. Meth., 1986, 88, 26.
J.H. Nunberg et al., J. Cell Biochem., 1988, Supp. 128, 12.
A. C. Ochoa et al., Cancer Res., 1989, 49, 963.
A. C. Ochoa et al., J. Immunol., 1987, 138, 2728.
J. R. Ortaldo et al., Int. J. Cancer, 1983, 31, 285.
G. Poste et al., Cancer Research, 1979, 39, 881.
M. J. Poznansky and R. L. Juliano, Pharmacol. Rev., 1984, 36, 277.
H. Rabinowich et al., Cancer Res., 1987, 47, 173.
A. Rahman et al., Cancer Res., 1982, 42, 1817.
S. A. Rosenberg, in Important Advances in Oncology, V.T. DeVita et al., eds., J.P. Lippincott Co., Philadelphia, Pennsylvania (1988) at pp. 217 to 257.
S. A. Rosenberg et al., J. Immunol, 1978, 121, 1951.
S. A. Rosenberg et al., Adv. Cancer Res., 1977, 25, 323.
S. A. Rosenberg et al., Ann. Int. Med., 1988, 108, 853.
S. A. Rosenberg et al., Ann. of Surg., 1988, 208, 121.
S. A. Rosenberg et al., N. Engl. J. Med., 1985, 313, 1485.
S. A. Rosenberg et al., N. Engl. J. Med., 1987, 316, 889.
S. A. Rosenberg et al., Science, 1986, 233, 1318.
D. G. Russell et al., J. Immunol., 1988, 140, 1274.
B. E. Ryman et al., Essays in Biochemistry, 1980, 16, 49.
R. R. Salup et al., Cancer Immunol. Immunother., 1986, 22, 31.
R. Schwab et al., J. Immunol., 1985, 135, 1714.
S. Shu et al., J. Immunol., 1986, 136, 3891.
S. Shu et al., J. Immunol., 1985, 135, 2895.
K. A. Smith, Science, 1988, 240, 1169.
S. Sone et al., Cell Immunol., 1981, 57, 42.
S. Sone et al., J. Immunol., 1980, 125, 2454.
G. Strauss et al., Proc. Natl. Acad. Sci. USA, 1986, 83, 2422.
G. Strauss et al., Biochem. Biophys. Acta, 1986, 858, 169.
J.L. Strausser et al., J. Immunol., 1978, 121, 1491.
A.B. Stavitsky, J. Immunol., 1954, 72, 360.
L. Tan et al., Biochemical Society Transactions, 1989, 17, 693.
V. von Fliedner et al., Progress in Chemical and Biological Research: Cellular Immunotherapy of Cancer, 1987, 244, 223.
B.M. Vose, Int. J. Cancer, 1982, 30, 135.
A. Weinberg et al., J. Immunol., 1988, 140, 294.
A. Weiss et al., J. Clin. Immunol., 1984, 4, 165.
T.L. Whiteside et al., Int. J. Cancer, 1986, 37, 803.
J.M. Williams et al., J. Immunol., 1985, 135, 2249.
J.M. Zarling et al., Nature, 1978, 274, 269.
O. Zumbuehl et al.
Anderson Peter M.
Leonard Arnold S.
Loeffler Cynthia
Ochoa Augusto C.
Hutzell Paula K.
Minnifield N. M.
Regents of the University of Minnesota
LandOfFree
Liposome immunoadjuvants containing IL-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liposome immunoadjuvants containing IL-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposome immunoadjuvants containing IL-2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1558605